NEURONAL INCLUSIONS OF PARKINSONS-DISEASE

被引:84
作者
GIBB, WRG
SCOTT, T
LEES, AJ
机构
[1] University Department of Neurology, King's College School of Medicine and Dentistry, London, Queen Square
[2] Neuropathology Department, National Hospitals for Nervous Diseases, London, Maida Vale, Queen Square
[3] National Hospital for Nervous Diseases, London, Queen Square
关键词
LEWY BODY; PALE BODY; PARKINSONS DISEASE; SUBSTANTIA NIGRA; LOCUS CERULEUS; FILAMENT;
D O I
10.1002/mds.870060103
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Two distinct neuronal inclusions occur in Parkinson's disease. The Lewy body is the diagnostic hallmark and is recognized by its eosinophilic body and unstained halo. It can be found in specific regions of the nervous system, where its frequency, size, shape, and structure differ. Large neurons of the dorsal vagal nucleus and sympathetic ganglia often contain particularly large quantities of Lewy-body-like matter. It consists of filament in the outer part and electron dense material in the core, the outer part staining with silver and with antibodies to neurofilament and tubulin. The pale body is restricted to the substantia nigra and locus ceruleus. It does not react with conventional stains, silver, or neurofilament antibodies, and has a homogeneous structure with a granular and vesicular surface texture. It contains sparse granular matter, vacuoles, and filaments, surrounded by melanin. The Lewy body and pale body may be juxtaposed or contiguous in some cells, but their distinct appearances and structures indicate that they are separate inclusions.
引用
收藏
页码:2 / 11
页数:10
相关论文
共 59 条
[1]  
Gibb WRG, Lees AJ., The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease, Neuropathol Appl Neurobiol, 15, pp. 27-44, (1989)
[2]  
Gibb WRG, Lees AJ., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry, 51, pp. 745-752, (1988)
[3]  
Hassler R., Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus, J Psychol Neurol, 48, pp. 387-476, (1938)
[4]  
Roy S, Wolman L., Ultrastructural observations in Parkinsonism, J Pathol, 99, pp. 39-44, (1969)
[5]  
Pappolla MA, Shank DL, Alzofon J, Dudley AW., Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease, Hum Pathol, 19, pp. 27-31, (1988)
[6]  
Gibb WRG, Esiri MM, Lees AJ., Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia), Brain, 110, pp. 1131-1153, (1987)
[7]  
Gibb WRG., The neuropathology of parkinsonian disorders, Parkinson's disease and movement disorders, pp. 205-223, (1988)
[8]  
Gibb WRG., The diagnostic relevance of Lewy bodies and other inclusions in Parkinson's disease, Early diagnosis and preventive therapy in Parkinson's disease. Key topics in brain research, pp. 171-180, (1989)
[9]  
Gibb WRG, Luthert PJ, Janota I, Lantos PL., Cortical Lewy body dementia:clinical features and classification, J Neurol Neurosurg Psychiatry, 52, pp. 185-192, (1989)
[10]  
Gibb WRG., The pathology of parkinsonian disorders, Disorders of movement–clinical, pharmacological and physiological aspects, pp. 33-57, (1989)